Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease-Reference-Cited by-同舟云学术

Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease

Published:2024-08-26 Issue: Volume: Page:
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Marcoux Curtis M.,Alousi Amin M.^ORCID,Im Jin,Hill Laquisa C.,Smallbone Portia,Popat Uday^ORCID,Hosing Chitra,Kebriaei Partow^ORCID,Olson Amanda^ORCID,Mehta Rohtesh^ORCID,Chen George,Qazilbash Muzaffar^ORCID,Shpall Elizabeth,Champlin Richard C.^ORCID,Saliba Rima M.

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41409-024-02393-1.pdf

Reference25 articles.

1. Reshef R, Saber W, Bolaños-Meade J, Chen G, Chen YB, Ho VT, et al. Acute GVHD diagnosis and adjudication in a multicenter trial: a report from the BMT CTN 1202 biorepository study. JCO. 2021;39:1878–87.

2. MacMillan ML, Robin M, Harris AC, DeFor TE, Martin PJ, Alousi A, et al. A refined risk score for acute GVHD that predicts response to initial therapy, survival and transplant-related mortality. Biol Blood Marrow Transpl. 2015;21:761–7.

3. Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, et al. Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease. N Engl J Med. 2020;382:1800–10.

4. MacMillan ML, DeFor TE, Holtan SG, Rashidi A, Blazar BR, Weisdorf DJ. Validation of Minnesota acute graft-versus-host disease Risk Score. Haematologica. 2020;105:519–24.

5. Ardizzoia F, Lorentino F, Bruno A, Marktel S, Giglio F, Clerici D, et al. Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis. Haematologica. 2022;107:2748–51.